Market Tracker

02/21 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

3.95
Delayed Data
As of Feb 21
 -0.05 / -1.25%
Today’s Change
3.20
Today|||52-Week Range
23.62
0.00%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close4.00
Today’s open4.00
Day’s range3.90 - 4.05
Volume702,736
Average volume (3 months)1,556,770
Market cap$154.1M
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+1.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book0.82

Competitors

 Today’s
change
Today’s
% change
KURAKura Oncology Inc-0.25-3.47%
MRTXMirati Therapeutics ...-0.05-0.81%
GLYCGlycoMimetics Inc-0.13-2.00%
XENEXenon Pharmaceutical...-0.05-0.60%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts